Model-based dose selection and pharmacokinetic bridging of subcutaneous from intravenous pembrolizumab across indications
European Journal of Cancer · 2025-11 · 230 · 115711
DOI: 10.1016/j.ejca.2025.115711 ↗Kurz gefasst
Metaanalyse in der Zeitschrift European Journal of Cancer, 2025-11. Verfasst von Gina Song und 8 weiteren Autor:innen. Beteiligte Einrichtung: Merck & Co., Inc., Rahway, NJ, USA. Electronic address: gina.song@merck.com. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Immunological, Models, Biological, Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Merck Sharp and Dohme United Kingdom, MSD.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Merck & Co., Inc., Rahway, NJ, USA. Electronic address: gina.song@merck.com.
- Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Türkiye. Electronic address: ermanm1968@gmail.com.
- Department of Clinical Oncology, Sanatorio Parque, Rosario, Argentina. Electronic address: gastonmartinengo74@hotmail.com.
- Department of Oncoradiology, Bács-Kiskun Megyei Oktatókórház, Kecskemét, Hungary. Electronic address: kocsisjucidr@gmail.com.
- Medical Oncology, Clermont Oncology Center, Clermont, FL, USA. Electronic address: drgkunta@aorcorp.com.
- Department of Pulmonary Medicine, Peking Union Medical College Hospital, Beijing, People's Republic of China. Electronic address: mengzhaowang@sina.com.
Förderung
- Merck Sharp and Dohme United Kingdom
- MSD
Zitieren
APA
Song, G., Erman, M., Martinengo, G. L., Kocsis, J., Kunta, G., Wang, M., Yoshioka, H., de Miranda Silva, C., & Lala, M. (2025). Model-based dose selection and pharmacokinetic bridging of subcutaneous from intravenous pembrolizumab across indications. European Journal of Cancer, 230, 115711. https://doi.org/10.1016/j.ejca.2025.115711
Vancouver
Song G, Erman M, Martinengo GL, Kocsis J, Kunta G, Wang M, et al. Model-based dose selection and pharmacokinetic bridging of subcutaneous from intravenous pembrolizumab across indications. European Journal of Cancer. 2025;230:115711. doi:10.1016/j.ejca.2025.115711
BibTeX
@article{Song2025,
author = {Song, Gina and Erman, Mustafa and Martinengo, Gastón Lucas and Kocsis, Judit and Kunta, Gopal and Wang, Mengzhao and Yoshioka, Hiroshige and de Miranda Silva, Carolina and Lala, Mallika},
title = {Model-based dose selection and pharmacokinetic bridging of subcutaneous from intravenous pembrolizumab across indications},
journal = {European Journal of Cancer},
year = {2025},
volume = {230},
pages = {115711},
doi = {10.1016/j.ejca.2025.115711}
}
EUVIMED